Trading
Please use a PC Browser to access Register-Tadawul
Wells Fargo Maintains Overweight on BioMarin Pharmaceutical, Raises Price Target to $75
Share
BioMarin Pharmaceutical Inc.
BMRN
61.12
+0.91%